14.54
price up icon3.41%   0.48
after-market アフターアワーズ: 14.54
loading
前日終値:
$14.06
開ける:
$14.15
24時間の取引高:
68,226
Relative Volume:
0.31
時価総額:
$544.39M
収益:
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-1.76%
1か月 パフォーマンス:
+33.39%
6か月 パフォーマンス:
+16.60%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
Value
$14.09
$14.62
1週間の範囲:
Value
$13.43
$15.70
52週間の値動き範囲:
Value
$5.485
$31.13

Oruka Therapeutics Inc Stock (ORKA) Company Profile

Name
名前
Oruka Therapeutics Inc
Name
セクター
Healthcare (1163)
Name
電話
650-606-7910
Name
住所
855 OAK GROVE AVE., MENLO PARK
Name
職員
28
Name
Twitter
Name
次回の収益日
2024-11-04
Name
最新のSEC提出書
Name
ORKA's Discussions on Twitter

ORKA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ORKA
Oruka Therapeutics Inc
14.54 526.41M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Oruka Therapeutics Inc Stock (ORKA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-05-22 開始されました BTIG Research Buy
2025-02-04 開始されました Wolfe Research Outperform
2024-10-11 開始されました Stifel Buy
2024-10-07 開始されました H.C. Wainwright Buy
2024-09-17 開始されました Leerink Partners Outperform
2024-09-16 開始されました TD Cowen Buy
2024-09-13 開始されました Jefferies Buy
2018-02-27 開始されました Ascendiant Capital Markets Buy
2013-10-09 開始されました Dawson James Buy
すべてを表示

Oruka Therapeutics Inc (ORKA) 最新ニュース

pulisher
03:02 AM

What drives Oruka Therapeutics Inc. stock priceOverwhelming financial success - Autocar Professional

03:02 AM
pulisher
09:40 AM

Is Oruka Therapeutics Inc. a good long term investmentAccelerated investment success - Autocar Professional

09:40 AM
pulisher
08:01 AM

H.C. Wainwright reiterates Buy rating on Oruka Therapeutics stock as FDA clears IND - Investing.com Canada

08:01 AM
pulisher
04:25 AM

Oruka Therapeutics Shares Climb After FDA Greenlights Psoriasis Drug Trial - MSN

04:25 AM
pulisher
03:44 AM

Oruka Therapeutics Inc. Stock Analysis and ForecastMassive profits - Autocar Professional

03:44 AM
pulisher
02:33 AM

What analysts say about Oruka Therapeutics Inc. stockExponential return rates - jammulinksnews.com

02:33 AM
pulisher
02:17 AM

Wedbush Reiterates Outperform Rating for Oruka Therapeutics (NASDAQ:ORKA) - Defense World

02:17 AM
pulisher
Jul 22, 2025

Oruka Therapeutics Announces IND Clearance for EVERLAST-A - GlobeNewswire

Jul 22, 2025
pulisher
Jul 21, 2025

Oruka Therapeutics stock rises after FDA clears IND for psoriasis drug - Investing.com India

Jul 21, 2025
pulisher
Jul 21, 2025

Stifel reiterates Buy rating on Oruka Therapeutics stock with $47 target - Investing.com Canada

Jul 21, 2025
pulisher
Jul 21, 2025

Oruka Therapeutics: Revolutionizing Psoriasis Treatment with Extended-Dosing Biologics - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

FDA clears Oruka’s IND for psoriasis drug ORKA-001 phase 2a trial - Investing.com India

Jul 21, 2025
pulisher
Jul 21, 2025

Oruka Therapeutics Announces IND Clearance for EVERLAST-A Phase 2a Trial of ORKA-001 in Psoriasis with Phase 1 Data to be Presented at EADV in September - Yahoo Finance

Jul 21, 2025
pulisher
Jul 18, 2025

How high can Oruka Therapeutics Inc. stock price go in 2025Balanced Risk Reward Portfolio - Newser

Jul 18, 2025
pulisher
Jul 15, 2025

How Oruka Therapeutics Inc. stock performs during market volatilityDaily Volume Leaders - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Oruka Therapeutics Inc. stock attracts strong analyst attentionFree Real-Time Stock Data - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Oruka Therapeutics Inc. stock price move sharplyWeekly Big Movers - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Oruka Therapeutics, Inc. (NASDAQ:ORKA) Receives Consensus Rating of “Buy” from Analysts - Defense World

Jul 15, 2025
pulisher
Jul 04, 2025

Oruka Therapeutics announces COO appointment - MSN

Jul 04, 2025
pulisher
Jul 02, 2025

Oruka Therapeutics Shares Soar 16.1% on Executive Promotion, Index Inclusion - AInvest

Jul 02, 2025
pulisher
Jul 01, 2025

Oruka Therapeutics Promotes Laura Sandler to COO - MarketScreener

Jul 01, 2025
pulisher
Jul 01, 2025

Oruka Therapeutics promotes Laura Sandler to chief operating officer - Investing.com

Jul 01, 2025
pulisher
Jul 01, 2025

Oruka Therapeutics Announces Promotion of Laura Sandler to Chief Operating Officer - GlobeNewswire

Jul 01, 2025
pulisher
Jul 01, 2025

Oruka Therapeutics Appoints New Chief Operating Officer - TipRanks

Jul 01, 2025
pulisher
Jun 29, 2025

Oruka Therapeutics, Inc.(NasdaqGM: ORKA) added to Russell 3000E Index - MarketScreener

Jun 29, 2025
pulisher
Jun 20, 2025

Oruka Therapeutics, Inc. (NASDAQ:ORKA) Given Average Recommendation of “Buy” by Analysts - Defense World

Jun 20, 2025
pulisher
Jun 14, 2025

Wall Street Zen Downgrades Oruka Therapeutics (NASDAQ:ORKA) to Sell - Defense World

Jun 14, 2025
pulisher
Jun 08, 2025

Millennium Management LLC Makes New Investment in Oruka Therapeutics, Inc. (NASDAQ:ORKA) - Defense World

Jun 08, 2025

Oruka Therapeutics Inc (ORKA) 財務データ

Oruka Therapeutics Inc (ORKA) の財務データはありません。詳細については、他の銘柄を確認してください。

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
大文字化:     |  ボリューム (24 時間):